Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BioBag Zenzo A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.1% 2.1%   Bankruptcy risk   1.2% 4.5% 2.9% 3.2% 1.2% 1.6% 8.9% 8.9%   Credit score (0-100)   84 48 58 54 81 73 28 28   Credit rating   A BBB BBB BBB A A BB BB   Credit limit (kDKK)   202.9 0.0 0.0 0.0 126.4 16.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   6,566 4,520 4,221 3,815 4,472 5,602 0.0 0.0   EBITDA   2,075 157 152 503 1,098 2,255 0.0 0.0   EBIT   2,071 151 152 503 1,098 2,255 0.0 0.0   Pre-tax profit (PTP)   2,013.5 110.7 111.4 466.3 1,042.7 2,247.1 0.0 0.0   Net earnings   1,566.3 85.5 86.8 362.5 811.1 1,752.7 0.0 0.0   Pre-tax profit without non-rec. items   2,013 111 111 466 1,043 2,247 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,799 2,085 2,171 2,534 3,345 5,098 3,198 3,198   Interest-bearing liabilities   30.2 996 42.8 297 133 1,430 0.0 0.0   Balance sheet total (assets)   7,714 7,879 6,456 10,144 8,137 13,820 3,198 3,198   Net Debt   -4,096 104 -4,207 -5,552 -2,357 672 -3,198 -3,198     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   6,566 4,520 4,221 3,815 4,472 5,602 0.0 0.0   Gross profit growth   0.3% -31.2% -6.6% -9.6% 17.2% 25.3% -100.0% 0.0%   Employees   7 7 7 5 5 5 0 0   Employee growth %   16.7% 0.0% 0.0% -28.6% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,714 7,879 6,456 10,144 8,137 13,820 3,198 3,198   Balance sheet change%   -29.6% 2.1% -18.1% 57.1% -19.8% 69.8% -76.9% 0.0%   Added value   2,074.7 156.7 151.8 502.8 1,097.8 2,254.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -7 -11 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   31.5% 3.4% 3.6% 13.2% 24.6% 40.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.2% 1.9% 2.1% 6.1% 12.0% 21.0% 0.0% 0.0%   ROI %   60.3% 4.3% 5.3% 17.1% 27.5% 37.7% 0.0% 0.0%   ROE %   45.9% 2.9% 4.1% 15.4% 27.6% 41.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   49.2% 26.5% 33.6% 26.6% 41.1% 37.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -197.4% 66.3% -2,770.9% -1,104.2% -214.7% 29.8% 0.0% 0.0%   Gearing %   0.8% 47.8% 2.0% 11.7% 4.0% 28.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   380.6% 7.9% 7.8% 21.5% 25.6% 7.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.9 1.3 1.5 1.5 2.1 1.8 0.0 0.0   Current Ratio   1.9 1.4 1.6 1.4 2.2 1.8 0.0 0.0   Cash and cash equivalent   4,125.8 891.9 4,249.9 5,849.0 2,490.9 757.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,705.1 2,122.8 2,346.4 3,003.5 4,347.7 6,096.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   296 22 22 101 220 451 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   296 22 22 101 220 451 0 0   EBIT / employee   296 22 22 101 220 451 0 0   Net earnings / employee   224 12 12 73 162 351 0 0